Abstracts - Association for Chemoreception Sciences
Abstracts - Association for Chemoreception Sciences
Abstracts - Association for Chemoreception Sciences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P O S T E R S<br />
#P322 POSTER SESSION VII:<br />
OLFACTORY PSYCHOPHYSICS &<br />
CLINICAL STUDIES; CENTRAL OLFACTION<br />
Investigation of detection and pain thresholds at different sites<br />
at the human nasal mucosa in healthy subjects and patients<br />
with chronic rhinosinusitis<br />
Mandy Scheibe, Annika Schmidt<br />
Ent Department Dresden, Germany<br />
Background: Previous investigations in humans suggest<br />
topographical differences in the arrangement of intranasal<br />
trigeminal chemosensitivity with the highest sensitivity in the<br />
anterior part of the nasal cavity. The aim of the present study<br />
was to investigate if different sites at the human nasal mucosa<br />
react differently to unspecific electrical stimuli and if there are<br />
differences in healthy subjects and patients. Material and<br />
Methods: A total of 50 young, healthy volunteers (24 men,<br />
26 women; age 22-38 years) and 10 patients with nasal polyps<br />
prior sinus surgery (6 men, 4 women; age 19 - 43 years)<br />
participated. Detection and pain threshold of trigeminal stimuli of<br />
the healthy subjects and the patients were investigated at 5<br />
different sites at the nasal mucosa: anterior septum, posterior<br />
septum, lower turbinate, middle turbinate and anterior lateral<br />
nasal wall. Electrical stimuli were applied with a spherical<br />
electrode. Results: In healthy subjects a significantly higher<br />
trigeminal sensitivity was found at the anterior parts of the nose<br />
compared to the posterior part. There was a similar distribution<br />
pattern of the sensitivity <strong>for</strong> detection and pain thresholds. In<br />
patients there was a higher detection thresholds compared to<br />
healthy subjects, interestingly. Conclusions: The present data<br />
suggest that there are topographical differences in the arrangement<br />
of trigeminal neurons at the human nasal cavity. The highest<br />
sensitivity seems to be located in the anterior part of the nasal<br />
cavity. This finding is compatible with the idea that the trigeminal<br />
system acts as a sentinel of the human airways with regard to toxic<br />
agents. In case of the patients with chronic rhinosinusitis the<br />
sensitivity of the nasal mucosa seems to be reduced which may<br />
contribute to the sensation of a “congested nose”.<br />
#P323 POSTER SESSION VII:<br />
OLFACTORY PSYCHOPHYSICS &<br />
CLINICAL STUDIES; CENTRAL OLFACTION<br />
Odors, Asthma and Risk Perception<br />
Cristina Jaen, Pamela H. Dalton<br />
Monell Chemical Senses Center Philadelphia, PA, USA<br />
Fragrances and strong odors have been characterized as a putative<br />
trigger that may exacerbate asthma symptoms and many<br />
asthmatics readily avoid odors and fragranced products. However,<br />
the mechanism by which exposure to pure odorants can elicit an<br />
adverse reaction in asthmatic patients is still unclear and may<br />
involve both physiological and psychological processes. The aim<br />
of this study was to investigate how beliefs about an odor’s<br />
relationship to asthmatic symptoms could affect the physiological<br />
and psychological responses of asthmatics. Asthmatics classified<br />
as ‘moderate-persistent’, according to NIH criteria, were exposed<br />
<strong>for</strong> 15 minutes to a fragrance which was described either as<br />
eliciting or alleviating asthma symptoms. During exposure,<br />
participants were asked to rate odor intensity, perceived irritation<br />
and subjective annoyance while physiological parameters such as<br />
electrocardiogram, respiratory rate, and end tidal carbon dioxide<br />
(EtCO2) were recorded. Be<strong>for</strong>e, immediately after, and at 2 and 24<br />
hours post-exposure, participants were required to subjectively<br />
assess their asthma symptom status using a standardized<br />
questionnaire. We also measured asthma status at each of those<br />
time points using objective parameters of bronchoconstriction<br />
(spirometry) and measures of airway inflammation (exhaled nitric<br />
oxide -eNO). Predictably, manipulations of perceived risk altered<br />
both the quality ratings of the fragrance as well as the reported<br />
levels of asthma symptoms. However, perceived risk also<br />
appeared to modulate the inflammatory airway response,<br />
suggesting that stress elicited by the instructions may affect<br />
airway physiology and impact asthma exacerbations.<br />
Acknowledgements: Supported by NIH-NIDCD grant number<br />
RO1 DC 003704 to PD.<br />
#P324 POSTER SESSION VII:<br />
OLFACTORY PSYCHOPHYSICS &<br />
CLINICAL STUDIES; CENTRAL OLFACTION<br />
“Olfaction in Burning Mouth Syndrome”<br />
Yuri L. Yakov, Svetlana Yakov, Alan R. Hirsch<br />
Smell &Taste Treatment and Research Foundation Chicago, IL,<br />
USA<br />
Objective: While Burning Mouth Syndrome (BMS) has been<br />
linked to disorders of taste, a <strong>for</strong>mal assessment of olfaction has<br />
not been entertained. Background: BMS is a condition of chronic<br />
neuropathic pain affecting the tongue and other intraoral<br />
structures in more then one million Americans. Methods:<br />
Retrospective chart review of the most recent 22 BMS patients<br />
(7 males, 15 females) was assessed <strong>for</strong> olfactory complaints and<br />
testing. Results: Average age was 59 years (males) and 54 years<br />
(females), the severity of burning on a scale of 1 to 10 was 7. Fifty<br />
five percent of patients (12 out of 22) had at least one olfactory<br />
complaint as follows: hyposmia - 55%, dysosmia – 23%, and<br />
phantosmia – 14%. Twenty patients (90%) who per<strong>for</strong>med<br />
olfactory tests had abnormal results bilaterally. Forty one percent<br />
of these patients had 1 test abnormal, 9% of these patients – 2<br />
tests, 27% - 3 tests and 14% - 4 tests abnormal. Of those who<br />
per<strong>for</strong>med the Brief Smell Identification Test corrected <strong>for</strong> age and<br />
sex - 4 out of 9 (44 %) had abnormal results; Alcohol<br />
Suprathreshold Testing – 11 out of 14 (79%); Smell Threshold<br />
Test with phenyl ethyl alcohol – 8 out of 10 (80%) patients had<br />
abnormal results in both nostrils tested individually; Quick Smell<br />
Identification Test - 9 out of 19 (47%); the Pocket Smell Test – 6<br />
out 16 (38%); the unilateral University of Pennsylvania Smell<br />
Identification Test corrected <strong>for</strong> age and sex – 5 out of 7 (71%)<br />
patients had abnormal results in both nostrils tested individually.<br />
The incidence of chemosensory complaints in the general<br />
population is approximately 5%, whereas the incidence of<br />
chemosensory complaints and dysfunction in those with BMS was<br />
far greater (55%). Conclusion: Beside taste dysfunction, BMS<br />
may manifest as a generalized chemosensory disorder.<br />
134 | AChemS <strong>Abstracts</strong> 2010<br />
<strong>Abstracts</strong> are printed as submitted by the author(s)